USANA Health Sciences (NYSE:USNA) Hits New 1-Year Low - What's Next?

Shares of USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) hit a new 52-week low on Tuesday . The company traded as low as $26.74 and last traded at $26.87, with a volume of 26579 shares changing hands. The stock had previously closed at $27.24.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on USNA shares. Sidoti lowered shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 18th. StockNews.com lowered shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Finally, DA Davidson dropped their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research note on Thursday, February 27th.

USANA Health Sciences Price Performance

The firm has a market capitalization of $526.37 million, a PE ratio of 9.84, a P/E/G ratio of 0.93 and a beta of 0.98. The company has a 50-day moving average price of $31.15 and a 200-day moving average price of $35.09.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.49 by $0.15. The company had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. On average, research analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Remove Ads

Insider Buying and Selling

In other news, insider Joshua Foukas sold 5,732 shares of the company's stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total transaction of $186,519.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jim Brown sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the sale, the chief executive officer now directly owns 15,716 shares in the company, valued at $463,150.52. This represents a 24.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,920 shares of company stock worth $500,285. 0.33% of the stock is owned by insiders.

Institutional Trading of USANA Health Sciences

Several institutional investors have recently made changes to their positions in the stock. R Squared Ltd purchased a new position in shares of USANA Health Sciences in the 4th quarter worth $28,000. Safe Harbor Fiduciary LLC purchased a new position in shares of USANA Health Sciences in the 3rd quarter worth about $30,000. KLP Kapitalforvaltning AS purchased a new position in shares of USANA Health Sciences in the 4th quarter worth about $83,000. Quantbot Technologies LP acquired a new position in shares of USANA Health Sciences in the 4th quarter valued at about $132,000. Finally, Meeder Asset Management Inc. purchased a new stake in shares of USANA Health Sciences during the 4th quarter worth about $143,000. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.